A potential novel use for direct antiviral therapy

Authors

  • Emre Turer M.D., Ph.D.,

    1. Department of Medicine, Division of Gastroenterology, University of Texas Southwestern Medical Center and Parkland Hospital, Dallas, TX
    Search for more papers by this author
  • Don C. Rockey M.D.,

    1. Department of Medicine, Division of Gastroenterology, University of Texas Southwestern Medical Center and Parkland Hospital, Dallas, TX
    Search for more papers by this author
  • Amit G. Singal M.D., M.S.

    Corresponding author
    1. Department of Medicine, Division of Gastroenterology, University of Texas Southwestern Medical Center and Parkland Hospital, Dallas, TX
    2. Department of Clinical Sciences, University of Texas Southwestern, Dallas, TX
    • Dedman Scholar of Clinical Care, Division of Gastroenterology, University of Texas Southwestern, 5959 Harry Hines Boulevard, POB 1, Suite 420, Dallas, TX 75390-8887
    Search for more papers by this author
    • fax: 214-645-6294


  • Potential conflict of interest: Dr. Rockey consults for and received grants from Hyperion and ONO Pharmaceutical. He received grants from Actelion and Gilead.

No abstract is available for this article.

Ancillary